Utilization of high molecular weight cytokeratin on prostate needle biopsies in an independent laboratory.

[1]  J. Epstein,et al.  The Utility of Basal Cell—Specific Anti‐Cytokeratin Antibody (34βE12) in the Diagnosis of Prostate Cancer: A Review of 228 Cases , 1995, The American journal of surgical pathology.

[2]  D. Bostwick,et al.  Atypical Basal Cell Hyperplasia of the Prostate: Immunophenotypic Profile and Proposed Classification of Basal Cell Proliferations , 1993, The American journal of surgical pathology.

[3]  J. Epstein,et al.  Nucleoli in low-grade prostate adenocarcinoma and adenosis. , 1993, Human pathology.

[4]  J. Epstein,et al.  Acidic mucin in the prostate: can it differentiate adenosis from adenocarcinoma? , 1992, Human pathology.

[5]  J. Epstein,et al.  Atypical Basal Cell Hyperplasia of the Prostate , 1992, The American journal of surgical pathology.

[6]  G. Collina,et al.  Sclerosing adenosis of the prostate. Report of three cases with electronmicroscopy and immunohistochemical study , 1992, Histopathology.

[7]  D. Grignon,et al.  Sclerosing Adenosis of the Prostate Gland: A Lesion Showing Myoepithelial Differentiation , 1992, The American journal of surgical pathology.

[8]  M. Enjoji,et al.  Sclerosing Adenosis of the Prostate Histopathologic and Immunohistochemical Analysis , 1991, The American journal of surgical pathology.

[9]  N. Ordóñez,et al.  Clear cell cribriform hyperplasia of the prostate. Immunohistochemical and DNA flow cytometric study. , 1991, American journal of clinical pathology.

[10]  J. Lechago,et al.  Cytokeratin immunohistochemistry as a diagnostic tool for distinguishing malignant from benign epithelial lesions of the prostate. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[11]  J. Epstein,et al.  A case showing sclerosing adenosis and an unusual form of basal cell hyperplasia of the prostate. , 1989, The American journal of surgical pathology.

[12]  J. Epstein,et al.  Use of Keratin 903 as an Adjunct in the Diagnosis of Prostate Carcinoma , 1989, The American journal of surgical pathology.

[13]  F. Freiha,et al.  Keratin immunoreactivity as an aid to the diagnosis of persistent adenocarcinoma in irradiated human prostates , 1989, Cancer.

[14]  D. Grignon,et al.  Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. , 1988, Human pathology.

[15]  L. Layfield,et al.  Keratin immunoreactivity in fine‐needle aspiration of the prostate: An aid in the differentiation of benign epithelium from well‐differentiated adenocarcinoma , 1988, Diagnostic cytopathology.

[16]  D. Bostwick,et al.  Prostatic Intra‐Epithelial Neoplasia and Early Invasion in Prostate Cancer , 1987, Cancer.

[17]  R. Nagle,et al.  Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. , 1987, Cancer research.

[18]  T. Stamey,et al.  Keratin immunoreactivity in the benign and neoplastic human prostate. , 1985, Cancer research.

[19]  A. Gown,et al.  Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues. , 1984, The American journal of pathology.

[20]  W. Scott,et al.  ULTRASTRUCTURE OF THE HUMAN PROSTATE: NORMAL AND NEOPLASTIC. , 1964, Laboratory investigation; a journal of technical methods and pathology.

[21]  E. Sproul,et al.  Microscopic differential diagnosis of latent carcinoma of prostate. , 1953, A.M.A. archives of pathology.